Unicycive Therapeutics, Inc. (UNCY) Misses Q1 EPS by 51c

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q1 EPS of ($0.61), $0.51 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Active options: AMD SNDK IREN GOOGL PLTR AVGO SOFI NKE MSTR NBIS ORCL
• China retail sales growth slows to 0.6% in July, Macquarie comments